MICHAEL JAMES OVERMAN to Class I Phosphatidylinositol 3-Kinases
This is a "connection" page, showing publications MICHAEL JAMES OVERMAN has written about Class I Phosphatidylinositol 3-Kinases.
Connection Strength
0.051
-
Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies. Oncotarget. 2015 May 20; 6(14):12809-21.
Score: 0.027
-
Target-based therapeutic matching in early-phase clinical trials in patients with advanced colorectal cancer and PIK3CA mutations. Mol Cancer Ther. 2013 Dec; 12(12):2857-63.
Score: 0.024